At the HealthLeaders Revenue Cycle Technology Mastermind forum this week in Savannah, RCM executives talked of how AI is giving them a new profile – and compelling them to work more closely with ...
BioCryst Pharmaceuticals, Inc. acquires Astria Therapeutics for ~$700M, aiming to bolster its HAE portfolio. Learn more about ...
Remote patient monitoring that relies only on text messages could help drive engagement, compliance and outcomes at scale.
This article outlines common CMC problems that are obstacles that steal momentum and create costly detours in the development ...
ART26.12 Phase 1 Data Demonstrated No Safety Concerns, Predictable Linear Plasma Exposure, and Options for Dosing in Either Fed or Fasted Conditions ...
Join the Johns Hopkins Institute for Clinical and Translational Research on Thursday, Nov. 20, at 2 p.m. for its next Third Thursdays with the ICTR lecture to learn about OpenSpecimen. OpenSpecimen is ...
To lead in the agentic era, executives must champion synthetic data as a foundation for innovation, while pairing it with ...
EssilorLuxottica added to its medical technology portfolio with the acquisition of Ikerian AG, a Swiss health tech company ...
Results indicate potential best-in-class RSV+hMPV±PIV3 combination vaccines, with the potential ability to re-vaccinate individuals previously receiving approved RSV vaccines to restore and broaden pr ...
Researchers identify FGFR4, FLT1, and WNT5A as key biomarkers and suggest dovitinib and nintedanib as new targeted therapies ...
OS Therapies Inc. (NYSE American: OSTX) (“OS Therapies” or “the Company”), a clinical-stage cancer immunotherapy and antibody drug ...
1don MSN
This Drug Discovery Stock Is Leading the Charge In Bringing AI to Healthcare. But Is It a Buy?
While AI can't shorten the testing process, it could make the initial discovery process significantly more efficient by ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback